HIV-1 Tat Promotes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6-Induced Angiogenesis and Tumorigenesis by Regulating PI3K/PTEN/AKT/GSK-3β Signaling Pathway

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zhou, Feng ^a,b   Xue, Min ^a,b   Qin, Di ^a   Zhu, Xiaofei ^a   Wang, Cong ^c   Zhu, Jianzhong ^d   Hao, Tingting ^a   Cheng, Lin ^a   Chen, Xiuying ^a   Bai, Zhiqiang ^a   Feng, Ninghan ^c   Gao, Shou Jiang ^e   Lu, Chun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD31 ANTIGEN; CD34 ANTIGEN; CYCLIN D1; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMOOTH MUSCLE ACTIN; TRANSACTIVATOR PROTEIN; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG TARGETING; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; CHORIOALLANTOIC MEMBRANE; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HERPESVIRUS 8, HUMAN; HIV-1; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871736842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053145     Document Type: Article

References (46)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
2. Greene W, Kuhne K, Ye F, Chen J, Zhou F, et al. (2007) Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res 133: 69-127.
3. Mesri EA, Cesarman E, Boshoff C, (2010) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10: 707-719.
4. Gallo RC, (1998) The enigmas of Kaposi's sarcoma. Science 282: 1837-1839.
5. Beral V, Peterman TA, Berkelman RL, Jaffe HW, (1990) Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335: 123-128.
6. Wood NH, Feller L, (2008) The malignant potential of HIV-associated Kaposi sarcoma. Cancer Cell Int 8: 14.
7. Rusnati M, Presta M, (2002) HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis 5: 141-151.
8. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, et al. (1994) Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371: 674-680.
9. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, et al. (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 81: 2401-2417.
10. Chen X, Cheng L, Jia X, Zeng Y, Yao S, et al. (2009) Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice. Neoplasia 11: 1272-1284.
11. Ziegelbauer JM, (2011) Functions of Kaposi's sarcoma-associated herpesvirus microRNAs. Biochim Biophys Acta 1809: 623-630.
12. Ganem D, (2010) KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120: 939-949.
13. Adam N, Rabe B, Suthaus J, Grotzinger J, Rose-John S, et al. (2009) Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor. J Virol 83: 5117-5126.
14. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS, (2002) Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298: 1432-1435.
15. Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, et al. (1999) Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93: 4034-4043.
16. Martin D, Galisteo R, Molinolo AA, Wetzker R, Hirsch E, et al. (2011) PI3Kgamma mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis. Cancer Cell 19: 805-813.
17. Guo HG, Pati S, Sadowska M, Charurat M, Reitz M, (2004) Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol 78: 9336-9342.
18. Sgarbanti M, Arguello M, tenOever BR, Battistini A, Lin R, et al. (2004) A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions. Oncogene 23: 5770-5780.
19. Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, et al. (2011) Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J Mol Biol 410: 1035-1051.
20. Qin D, Feng N, Fan W, Ma X, Yan Q, et al. (2011) Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1. BMC Microbiol 11: 240.
21. Deng H, Song MJ, Chu JT, Sun R, (2002) Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol 76: 8252-8264.
22. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
23. Agwale SM, Shata MT, Reitz MS Jr, Kalyanaraman VS, Gallo RC, et al. (2002) A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice. Proc Natl Acad Sci U S A 99: 10037-10041.
24. Boykins RA, Mahieux R, Shankavaram UT, Gho YS, Lee SF, et al. (1999) Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis. J Immunol 163: 15-20.
25. Aranda E, Owen GI, (2009) A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol Res 42: 377-389.
26. Tang Q, Qin D, Lv Z, Zhu X, Ma X, et al. (2012) Herpes Simplex Virus Type 2 Triggers Reactivation of Kaposi's Sarcoma-Associated Herpesvirus from Latency and Collaborates with HIV-1 Tat. PLoS One 7: e31652.
27. Suthaus J, Adam N, Grotzinger J, Scheller J, Rose-John S, (2011) Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Eur J Cell Biol 90: 495-504.
28. Burger R, Neipel F, Fleckenstein B, Savino R, Ciliberto G, et al. (1998) Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91: 1858-1863.
29. Moore PS, Boshoff C, Weiss RA, Chang Y, (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274: 1739-1744.
30. Wan X, Wang H, Nicholas J, (1999) Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol 73: 8268-8278.
31. Harrington W Jr, Sieczkowski L, Sosa C, Chan-a-Sue S, Cai JP, et al. (1997) Activation of HHV-8 by HIV-1 tat. Lancet 349: 774-775.
32. Barillari G, Gendelman R, Gallo RC, Ensoli B, (1993) The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A 90: 7941-7945.
33. Cantaluppi V, Biancone L, Boccellino M, Doublier S, Benelli R, et al. (2001) HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. AIDS Res Hum Retroviruses 17: 965-976.
34. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, et al. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287.
35. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F, (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 84-86.
36. Geras-Raaka E, Varma A, Ho H, Clark-Lewis I, Gershengorn MC, (1998) Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Exp Med 188: 405-408.
37. Selby MJ, Bain ES, Luciw PA, Peterlin BM, (1989) Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev 3: 547-558.
38. Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, et al. (1999) Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med 5: 643-650.
39. Lempiainen H, Halazonetis TD, (2009) Emerging common themes in regulation of PIKKs and PI3Ks. EMBO J 28: 3067-3073.
40. Montaner S, (2007) Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle 6: 438-443.
41. Morris VA, Punjabi AS, Lagunoff M, (2008) Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J Virol 82: 8771-8779.
42. Engelman JA, (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9: 550-562.
43. Jiang BH, Liu LZ, (2009) PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102: 19-65.
44. Engelman JA, Luo J, Cantley LC, (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
45. Deregibus MC, Cantaluppi V, Doublier S, Brizzi MF, Deambrosis I, et al. (2002) HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem 277: 25195-25202.
46. Pati S, Foulke JS Jr, Barabitskaya O, Kim J, Nair BC, et al. (2003) Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol 77: 5759-5773.